CRNO B — Cereno Scientific AB Share Price
Last trade - 00:00- SEK65.73m
- SEK21.51m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.33 | ||
| Price to Tang. Book | 1.9 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -13.57% | ||
| Return on Equity | -14.82% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cereno Scientific AB is a manufacturer of pharmaceutical preparation. The Company was founded in 1970 and is located in Gothenburg, Sweden.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- March 31st, 2023
- Incorporated
- April 12th, 2012
- Public Since
- June 22nd, 2016
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- AktieTorget Stock Exchange
- Shares in Issue
- 137,514,844
- Address
- BioVentureHub, Pepparedsleden 1, MOELNDAL, 431 83
- Web
- https://www.cerenoscientific.se/
- Phone
- Auditors
- Frejs Revisorer AB
Upcoming Events for CRNO B
Similar to CRNO B
Abera Bioscience AB
AktieTorget Stock Exchange
Aptahem AB
AktieTorget Stock Exchange
Arcede Pharma AB
AktieTorget Stock Exchange
Carbiotix AB (publ)
AktieTorget Stock Exchange
Chosa Oncology AB
AktieTorget Stock Exchange
FAQ
As of Today at 19:04 UTC, shares in Cereno Scientific AB are trading at SEK0.48. This share price information is delayed by 15 minutes.
Shares in Cereno Scientific AB last closed at SEK0.48 and the price had moved by -87.9% over the past 365 days. In terms of relative price strength the Cereno Scientific AB share price has underperformed the FTSE Global All Cap Index by -88.59% over the past year.
There is no consensus recommendation for this security.
Cereno Scientific AB does not currently pay a dividend.
Cereno Scientific AB does not currently pay a dividend.
Cereno Scientific AB does not currently pay a dividend.
To buy shares in Cereno Scientific AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK0.48, shares in Cereno Scientific AB had a market capitalisation of SEK65.73m.
Here are the trading details for Cereno Scientific AB:
- Country of listing: Sweden
- Exchange: AKT
- Ticker Symbol: CRNO B
Based on an overall assessment of its quality, value and momentum Cereno Scientific AB is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Cereno Scientific AB is SEK2.10. That is 339.33% above the last closing price of SEK0.48.
Analysts covering Cereno Scientific AB currently have a consensus Earnings Per Share (EPS) forecast of -SEK0.20 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cereno Scientific AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -77.49%.
As of the last closing price of SEK0.48, shares in Cereno Scientific AB were trading -77.08% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Cereno Scientific AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.48.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Cereno Scientific AB's directors